Bcl6 is a subset-defining transcription factor of lymphoid tissue inducer-like ILC3
Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved..
Innate lymphoid cells (ILCs) are tissue-resident effector cells with roles in tissue homeostasis, protective immunity, and inflammatory disease. Group 3 ILCs (ILC3s) are classically defined by the master transcription factor RORγt. However, ILC3 can be further subdivided into subsets that share type 3 effector modules that exhibit significant ontological, transcriptional, phenotypic, and functional heterogeneity. Notably lymphoid tissue inducer (LTi)-like ILC3s mediate effector functions not typically associated with other RORγt-expressing lymphocytes, suggesting that additional transcription factors contribute to dictate ILC3 subset phenotypes. Here, we identify Bcl6 as a subset-defining transcription factor of LTi-like ILC3s in mice and humans. Deletion of Bcl6 results in dysregulation of the LTi-like ILC3 transcriptional program and markedly enhances expression of interleukin-17A (IL-17A) and IL-17F in LTi-like ILC3s in a manner in part dependent upon the commensal microbiota-and associated with worsened inflammation in a model of colitis. Together, these findings redefine our understanding of ILC3 subset biology.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:42 |
---|---|
Enthalten in: |
Cell reports - 42(2023), 11 vom: 28. Nov., Seite 113425 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Tachó-Piñot, Roser [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 06.12.2023 Date Revised 06.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.celrep.2023.113425 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM36442527X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM36442527X | ||
003 | DE-627 | ||
005 | 20240306232528.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.celrep.2023.113425 |2 doi | |
028 | 5 | 2 | |a pubmed24n1318.xml |
035 | |a (DE-627)NLM36442527X | ||
035 | |a (NLM)37950867 | ||
035 | |a (PII)S2211-1247(23)01437-7 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Tachó-Piñot, Roser |e verfasserin |4 aut | |
245 | 1 | 0 | |a Bcl6 is a subset-defining transcription factor of lymphoid tissue inducer-like ILC3 |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 06.12.2023 | ||
500 | |a Date Revised 06.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved. | ||
520 | |a Innate lymphoid cells (ILCs) are tissue-resident effector cells with roles in tissue homeostasis, protective immunity, and inflammatory disease. Group 3 ILCs (ILC3s) are classically defined by the master transcription factor RORγt. However, ILC3 can be further subdivided into subsets that share type 3 effector modules that exhibit significant ontological, transcriptional, phenotypic, and functional heterogeneity. Notably lymphoid tissue inducer (LTi)-like ILC3s mediate effector functions not typically associated with other RORγt-expressing lymphocytes, suggesting that additional transcription factors contribute to dictate ILC3 subset phenotypes. Here, we identify Bcl6 as a subset-defining transcription factor of LTi-like ILC3s in mice and humans. Deletion of Bcl6 results in dysregulation of the LTi-like ILC3 transcriptional program and markedly enhances expression of interleukin-17A (IL-17A) and IL-17F in LTi-like ILC3s in a manner in part dependent upon the commensal microbiota-and associated with worsened inflammation in a model of colitis. Together, these findings redefine our understanding of ILC3 subset biology | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Bcl6 | |
650 | 4 | |a CP: Immunology | |
650 | 4 | |a IL-17 | |
650 | 4 | |a ILC3 | |
650 | 4 | |a innate lymphoid cells | |
650 | 4 | |a intestinal immunity | |
650 | 4 | |a lymphoid tissue inducer | |
650 | 4 | |a microbiota | |
650 | 4 | |a transcription factor | |
650 | 7 | |a Bcl6 protein, mouse |2 NLM | |
650 | 7 | |a Nuclear Receptor Subfamily 1, Group F, Member 3 |2 NLM | |
650 | 7 | |a Proto-Oncogene Proteins c-bcl-6 |2 NLM | |
650 | 7 | |a Transcription Factors |2 NLM | |
650 | 7 | |a BCL6 protein, human |2 NLM | |
700 | 1 | |a Stamper, Christopher T |e verfasserin |4 aut | |
700 | 1 | |a King, James I |e verfasserin |4 aut | |
700 | 1 | |a Matei-Rascu, Veronika |e verfasserin |4 aut | |
700 | 1 | |a Richardson, Erin |e verfasserin |4 aut | |
700 | 1 | |a Li, Zhi |e verfasserin |4 aut | |
700 | 1 | |a Roberts, Luke B |e verfasserin |4 aut | |
700 | 1 | |a Bassett, John W |e verfasserin |4 aut | |
700 | 1 | |a Melo-Gonzalez, Felipe |e verfasserin |4 aut | |
700 | 1 | |a Fiancette, Rémi |e verfasserin |4 aut | |
700 | 1 | |a Lin, I-Hsuan |e verfasserin |4 aut | |
700 | 1 | |a Dent, Alexander |e verfasserin |4 aut | |
700 | 1 | |a Harada, Yohsuke |e verfasserin |4 aut | |
700 | 1 | |a Finlay, Conor |e verfasserin |4 aut | |
700 | 1 | |a Mjösberg, Jenny |e verfasserin |4 aut | |
700 | 1 | |a Withers, David R |e verfasserin |4 aut | |
700 | 1 | |a Hepworth, Matthew R |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Cell reports |d 2012 |g 42(2023), 11 vom: 28. Nov., Seite 113425 |w (DE-627)NLM217067492 |x 2211-1247 |7 nnns |
773 | 1 | 8 | |g volume:42 |g year:2023 |g number:11 |g day:28 |g month:11 |g pages:113425 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.celrep.2023.113425 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 42 |j 2023 |e 11 |b 28 |c 11 |h 113425 |